We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Hep C Patients Who Drink Three Cups Of Coffee Daily During Treatment Have Better Outcomes

March 2, 2011: 12:04 PM EST
Patients suffering from advanced hepatitis C and chronic liver disease who drank coffee while receiving peginterferon plus ribavirin treatment experienced better outcomes than non-coffee drinkers, according to a U.S. study. Researchers found that 46 percent of patients who did not drink coffee experienced an early virologic response to treatment, compared to 73 percent of coffee drinkers. Twenty-six percent of non-coffee drinkers had no detectable hepatitis C virus at week 20, compared to 52 percent of coffee drinkers. “High-level consumption of coffee (more than 3 cups per day) is an independent predictor of improved virologic response to peginterferon plus ribavirin in patients with hepatitis C,” the researchers concluded.
Neal D. Freedman, et al. , "Coffee Consumption is Associated with Response to Peginterferon and Ribavirin Therapy in Patients with Chronic Hepatitis C", Gastroenterology, March 02, 2011, © Elsevier Inc.
Diet Insights
Diet Research & Advice
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.